pembrolizumab,gemcitabine
merck
['pembro', 'gemcitabine', 'bladder', 'urothelial']
asco 2023: long-term outcomes of pembrolizumab in combination with gemcitabine and concurrent hypofractionated radiation therapy as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder: a multicenter phase 2 trial 
Radio-oncología , Ex jefe Unidad de RT HG México, Ex Profesor Titular curso especialidad Radioterapia UNAM - HG Mexico, Ex Presidente del Consejo Mexicano de RT